New Study Characterizes the Gut Virome
Washington, D.C. – October 19, 2021 - A new study has added numerous previously uncharacterized viral genomes and genes to the ever-increasing worldwide pool of human gut viromes. , an open-access journal of the American Society for °®¶¹´«Ã½, will prove helpful in investigating the role of the gut virome in human health and disease.
"The human gut virome is still vastly underexplored and many novel viruses are to be discovered, some of which could have important influences on processes impacting human health and disease," said study principal investigator Jelle Matthijnssens, Ph.D., a professor in the Department of °®¶¹´«Ã½, Immunology & Transplantation, Rega Institute, Division of Clinical & Epidemiological Virology, Laboratory of Viral Metagenomics, KU Leuven, Leuven, Belgium.
The human gut contains a complex ecosystem of microorganisms, of which bacteria have been broadly studied. Dr. Matthijnssens said studies on viruses in the gut are lagging. The goal of the is to obtain understanding of the interaction between the host and gut microbiome in humans and the role of the gut-liver axis in early stages of alcoholic and non-alcoholic fatty liver disease. "In the framework of the MicrobLiver project, we aimed to generate a catalogue of virus genomes, which could be used in subsequent studies on several cohorts of people with early stages of alcoholic and non-alcoholic fatty liver disease," said Dr. Matthijnssens.
In the new study, researchers used 254 fecal samples from 204 Danish subjects to generate the Danish Enteric Virome Catalog (DEVoC). The pediatric cohort included 50 children and adolescents (6-18 years old) with a body mass index (BMI) above the 90th percentile, together with 50 age- and sex-matched healthy controls. The adult cohort (34-76 years) included 52 patients with alcohol-related liver disease and 52 sex, BMI, and age-matched healthy controls.
The researchers used the Novel Enrichment Technique Of Viromes (NetoVIR) protocol to purify all virus particles from stool samples and sequenced their genomes using deep-sequencing technologies. (NetoVir allows researchers to attain a fast, reproducible, high-throughput sample preparation protocol for next-generation sequencing gut viromics studies.)
Furthermore, they used advanced bioinformatics tool to identify almost 13 thousand (partial) viral genomes, many of which were novel and not present in public databases.
Although gut viromes are known to be very individual specific, the researchers identified 39 genomes which were present in at least 10 healthy subjects. These 39 genomes were further compared with public virome datasets from all over the world showing several age, geography and disease-related prevalence patterns. In particular, 2 genomes showed a remarkably high prevalence worldwide. The first one was a crAss-like phage (20.6% prevalence), belonging to the tentative AlphacrAssvirinae subfamily, whereas the second one was a previously undescribed temperate phage infecting Bacteroides dorei (14.4% prevalence), called LoVEphage. The researchers next screened public databases and were able to retrieve 18 additional circular LoVEphage-like genomes (67.9 to 72.4 kb).
"Our findings further emphasize that the human gut virome is still understudied and that many novel viruses are to be discovered. Especially the identification of novel phages shared by people across the globe is of interest to be studied in more depth," said Dr. Matthijnssens. "Next, the catalogue will be used to further study differences in the virome of various cohorts of patients with early stages of alcoholic and non-alcoholic fatty liver disease. We hope these studies will provide us basic insight into the role the gut virome might have in the development of alcoholic and non-alcoholic fatty liver disease. Furthermore, we will look into the virome to identify biomarkers for disease progression or prediction of treatment success."
##
°®¶¹´«Ã½ is one of the largest professional societies dedicated to the life sciences and is composed of 30,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.
ASM advances the microbial sciences through conferences, publications, certifications, educational opportunities and advocacy efforts. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.   
